🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

26 recruiting trials

for Pediatric Malignant Solid Tumor

Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors NCT04222413Phase 12 sites📍 Fairway📍 Bethesda National Cancer Institute (NCI) · Tests: Metarrestin A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01) NCT06941272Phase 1, Phase 264 sites📍 Los Angeles📍 Aurora📍 New Haven Merck Sharp & Dohme LLC · Tests: Patritumab Deruxtecan Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors NCT05372640Phase 17 sites📍 Los Angeles📍 Los Angeles📍 Los Angeles National Cancer Institute (NCI) · Tests: Abemaciclib, BET Bromodomain Inhibitor ZEN-3694, Biopsy Procedure, Biospecimen Collection, Diagnostic Imaging Testing A Phase I, First in Human Study of CBA-1205, Anti-DLK1 Monoclonal Antibody in Patients With Advanced Solid Tumors, Hepatocellular Carcinoma (HCC), Melanoma, and Pediatric Cancer NCT06636435Phase 15 sites📍 Kashiwa📍 Yokohama📍 Niigata Chiome Bioscience Inc. · Tests: CBA-1205 Part 1, CBA-1205 Part 2, CBA-1205 Part 3, CBA-1205 Part 4, CBA-1205 Part 5 Tumor Infiltrating Lymphocyte Therapy for Pediatric High Risk Solid Tumors NCT06047977Phase 11 site📍 St. Petersburg H. Lee Moffitt Cancer Center and Research Institute · Tests: Tumor Infiltrating Lymphocytes, Fludarabine, Cyclophosphamide, Interleukin-2 A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients NCT05711667Phase 333 sites📍 Birmingham📍 Oakland📍 San Francisco Children's Oncology Group · Tests: Biospecimen Collection, Letermovir Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells NCT07148050Phase 11 site📍 Seattle Seattle Children's Hospital · Tests: SC-CAR.GPC3xIL15.21 CAR T cells B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR) NCT04897321Phase 11 site📍 Memphis St. Jude Children's Research Hospital · Tests: Fludarabine, Cyclophosphamide, MESNA, B7-H3 CAR T cells Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling NCT05857969Phase 11 site📍 Miami Florida International University · Tests: Functional Precision Medicine A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01) NCT07630974Phase 1, Phase 234 sites📍 Los Angeles📍 Aurora📍 St. Petersburg Merck Sharp & Dohme LLC · Tests: Ifinatamab Deruxtecan Liquid Biopsies in Pediatric Solid Tumors NCT05068583n/a1 site📍 Los Angeles Children's Hospital Los Angeles · Tests: Blood Draw A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors NCT05985161Phase 216 sites📍 Los Angeles📍 Palo Alto📍 Washington D.C. Memorial Sloan Kettering Cancer Center · Tests: Selinexor A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors NCT05135975Phase 26 sites📍 Birmingham📍 Aurora📍 Washington D.C. Nationwide Children's Hospital · Tests: Cabozantinib Natural History and Biospecimen Acquisition for Children and Adults With Rare Solid Tumors NCT03739827n/a3 sites📍 Bethesda📍 Portland📍 Houston National Cancer Institute (NCI) AIMS Cancer Outcomes Study NCT04495790n/a1 site📍 Seattle Advanced Integrative Medical Science Institute Phase II Study of QLC2519 in Pediatric Solid Tumor Participants NCT07724756Phase 21 site📍 Beijing Qilu Pharmaceutical Co., Ltd. · Tests: Albipagrastim alf A Study of ONO-4538HSC in Pediatric Patients With Malignant Solid Tumors and in Patients With Epithelioid Sarcoma. NCT07734116Phase 1, Phase 215 sites📍 Chiba📍 Kashiwa📍 Fukuoka Ono Pharmaceutical Co., Ltd. · Tests: ONO-4538HSC Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma NCT04901702Phase 1, Phase 210 sites📍 Palo Alto📍 Aurora📍 Washington D.C. St. Jude Children's Research Hospital · Tests: Onivyde, Talazoparib, Temozolomide Study of LAM561 Acid in Pediatric Patients With Malignant Glioma and Other Advanced Solid Tumors NCT04299191Phase 1, Phase 23 sites📍 Little Rock📍 Miami📍 Edison Laminar Pharmaceuticals · Tests: LAM561 Study Of Cold Cap Therapy For Prevention of Hairloss in Pediatric Patients Receiving Chemotherapy For Non-Malignant Indications and Solid Tumors NCT04764357NA1 site📍 Memphis St. Jude Children's Research Hospital · Tests: Paxman Scalp Cooling System, Alopecia Assessments, Patient Reported Outcomes Questionnaires Biomarkers of Resiliency In Childhood Cancer Surgery NCT06674811n/a1 site📍 Rochester Mayo Clinic · Tests: Wearing Smartwatch, Patient Report Outcomes, Blood Draw, Clinical Data Review An Imaging Agent (Pafolacianine) for Identifying Lesions in Pediatric Patients With Primary or Metastatic Solid Tumors NCT06915727Phase 31 site📍 Rochester Mayo Clinic · Tests: Biospecimen Collection, Near Infrared Imaging, Pafolacianine Sodium, Surgical Procedure Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors NCT04715191Phase 11 site📍 Houston Baylor College of Medicine · Tests: CARE T cells A Study of Pembrolizumab in Japanese Pediatric Participants With Solid Tumors or Lymphomas and Japanese Adult Participants With Merkel Cell Carcinoma (MK-3475-G21/KEYNOTE-G21) NCT07302347Phase 1, Phase 27 sites📍 Nagoya📍 Nagoya📍 Sapporo Merck Sharp & Dohme LLC · Tests: Pembrolizumab Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients NCT05468359Phase 1, Phase 22 sites📍 Germantown📍 Memphis St. Jude Children's Research Hospital · Tests: Atezolizumab, Sorafenib, Bevacizumab, Cyclophosphamide Clinical Trial of GAIA-102 for Refractory/Relapse Neuroblastomas and Other Malignant Pediatric Solid Tumors NCT05608148Phase 11 site📍 Fukuoka Kyushu University · Tests: Biological, Biological, Biological, Biological
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy